The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers

SIMPLE SUMMARY: We recently reported that the human TOR signaling regulator (hereafter TIPRL) contributes to the drug-resistance of hepatocellular carcinomas (HCCs) and the involvement of TIPRL/LC3/CD133 in liver cancer aggressiveness. This study aims to determine prognostic and diagnostic efficacie...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Cancers (Basel)
Main Authors: Jun, Soo Young, Yoon, Hyang Ran, Yoon, Ji-Yong, Jeon, Su-Jin, Lee, Jeong-Ju, Halder, Debasish, Kim, Jin-Man, Kim, Nam-Soon
Formáid: Artigo
Teanga:Inglês
Foilsithe: MDPI 2021
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8230774/
https://ncbi.nlm.nih.gov/pubmed/34208132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122925
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla